“The Diabetic Macular Edema Pipeline Insight report provides deep insights into emerging pipeline therapies for diabetic macular edema with an analysis of 60+ key players
A 501(c)(3) organization can research, publish, educate and argue about policy without limit. It can lobby, but only within a limit, and how that limit is measured depends on an election the organization either makes or does not. It cannot.
Five platforms that take apart marketplace settlements and post them correctly, ranked on how much manual work each removes, with the honest limitation of each.
In February 2026, a federal judge in Manhattan ruled that 31 documents a defendant generated with a consumer AI chatbot were not protected by attorney-client